Journals / Mehmet Akif Ersoy Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi / 2021 / Cilt: 9 - Sayı: 1

Effect of synthetic cannabinoids (JWH-018) on antibody response to HBV vaccination

Pages
21–26
Publication Date
2021-04-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, more data are needed to understand causation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Synthetic cannabinoids can affect the immune system and can cause some changes in immune response.
📊
Key Findings & Data:Studies on hepatitis B vaccine antibody response and JWH-018 are extremely limited.
💡
Conclusion & Impact:However, more data are needed to understand causation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Hepatitis B · Immunity · JWH-018

Abstract

Synthetic cannabinoids can affect the immune system and can cause some changes in immune response. The immune response to the Hepatit B vaccine is complex. Studies on hepatitis B vaccine antibody response and JWH-018 are extremely limited. The main aim of this study was to investigate the effect of JWH-018 on anti-HBs Ag changes before or after Hepatitis B vaccination. The study was performed on C57BL6 mice (n=25). Mice were divided into 3 groups. Control Group; it was immunized Engerix B at 3 times 3-week intervals. Group 1; JWH-018 (1 mg/kg) was administered once a week for 4 weeks. At the end of this period, Engerix B was immunized 3 times at 3-week intervals. Group 2; it was immunized 3 times at 3-weeks intervals with Engerix B. At the end of this period JWH-018 (1 mg/kg) was treated once a week for 4 weeks. Blood samples (3 times with an interval of 2 weeks) were collected at the end of drug and vaccine administration. It was calculated that the means obtained from the control group were lower than the other groups. The final measurement of the within-group was higher than other measures and was statistically significant (p=0,017). Statistical difference was measured in the first (p=0,018) and third measurements (p=0,005) of the between groups. A total of 5 mice from the experimental groups died at different stages of the study. In this study, the use of JWH-018 has been shown to be effective on the anti-HBs parameter. We think that our study is very valuable in terms of proving the relationship between JWH-018 and Anti-Hbs parameter. However, more data are needed to understand causation.

🔖

Cite This Article

KÖKSOY, S., BAŞALP, A. (2021). Effect of synthetic cannabinoids (JWH-018) on antibody response to HBV vaccination. Mehmet Akif Ersoy Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, Cilt: 9 - Sayı: 1, 21–26. https://ajindex.com/articles/790435

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Agudelo, M., Newton, C., Widen, R., Sherwood, T., Nong, L., et al. 2008. Cannabinoid receptor 2 (CB2) mediates immunoglobulin class switching from IgM to IgE in cultures of murine-purified B lymphocytes. J Neuroimmunol., 3(1), 35–42. DOI:10.1007/s11481-007-9088-9
  2. Aung, M.M., Griffin, G., Huffman, J.W., Wu, M., Keel, et al. 2000. Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding. Drug Alcohol Depend, 60(2), 133–140. DOI:10.1016/s0376-8716(99)00152-0
  3. Chen, L., Zhang, Y., Zhang, S., Chen, Y., Shu, X., et al. 2019. A novel T-cell epitope in the transmembrane region of the hepatitis B virus envelope protein responds upon dendritic cell expansion. Arch Virol., 164(2), 483–495. https://doi.org/10.1007/s00705-018-4095-0
  4. Croxford, J.L., & Yamamura, T. 2005. Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?. J Neuroimmunol., 166(1-2),3–18. DOI:10.1016/j.jneuroim.2005.04.023 Do, Y., McKallip, R.J., Nagarkatti, M., Nagarkatti, P.S., 2004. Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-κB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation. J Neuroimmunol. 173(4):2373-2382. DOI: 10.4049/jimmunol.173.4.2373 Eisenstein, T.K., & Meissler, J.J., 2015. Effects of Cannabinoids on T-cell Function and Resistance to Infection. J Neuroimmune Pharmacol, 10(2),204–216. DOI:10.1007/s11481-015-9603-3 EMCDDA., 2010. Annual report on the state of the drugs problem in Europe, Lisbon. Every-Palmer, S. 2011. Synthetic cannabinoid JWH-018 and psychosis: an explorative study. Drug Alcohol Depend, 117(2-3):152-157. DOI: 10.1016/j.drugalcdep.2011.01.012. Filippelli, M., Lionetti, E., Gennaro, A., Lanzafame, A., Arrigo, T., et al. 2014. Hepatitis B vaccine by intradermal route in non responder patients: an update. World J Gastroenterol, 20(30), 10383–10394. DOI:10.3748/wjg.v20.i30.10383 Floreani, A., Baldo, V., Cristofoletti, M., Renzulli G., et al. 2004. Long-term persistence of anti-HBs after vaccination against HBV: an 18 year experience in health care workers. Vaccine., 22(5)6,607- 610. DOI: 10.1016/j.vaccine.2003.09.001 Hermanns-Clausen, M., Kneisel, S., Szabo, B., Auwärter, V. 2013. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction (Abingdon, England), 108(3):534–544. DOI:10.1111/j.1360-0443.2012.04078.x Hou, J., Liu, Z., Gu, F. 2005. Epidemiology and p